263 related articles for article (PubMed ID: 8294873)
1. Macrophage inflammatory protein 1 alpha, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro.
Verfaillie CM; Catanzarro PM; Li WN
J Exp Med; 1994 Feb; 179(2):643-9. PubMed ID: 8294873
[TBL] [Abstract][Full Text] [Related]
2. CD34+/CD33- cells reselected from macrophage inflammatory protein 1 alpha+interleukin-3--supplemented "stroma-noncontact" cultures are highly enriched for long-term bone marrow culture initiating cells.
Verfaillie CM; Miller JS
Blood; 1994 Sep; 84(5):1442-9. PubMed ID: 7520771
[TBL] [Abstract][Full Text] [Related]
3. Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation.
Verfaillie CM
Blood; 1993 Oct; 82(7):2045-53. PubMed ID: 7691246
[TBL] [Abstract][Full Text] [Related]
4. Can human hematopoietic stem cells be cultured ex vivo?
Verfaillie CM
Stem Cells; 1994 Sep; 12(5):466-76. PubMed ID: 7528589
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
Miller JS; McCullar V; Verfaillie CM
Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
[TBL] [Abstract][Full Text] [Related]
6. Diffusible factors from the murine cell line M2-10B4 support human in vitro hematopoiesis.
Burroughs J; Gupta P; Blazar BR; Verfaillie CM
Exp Hematol; 1994 Oct; 22(11):1095-101. PubMed ID: 7523163
[TBL] [Abstract][Full Text] [Related]
7. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture.
Keil F; Chen X; Louda N; Zsuh H; Schneider B; Lechner K; Kalhs P; Greinix HT
Ann Hematol; 2000 May; 79(5):243-8. PubMed ID: 10870478
[TBL] [Abstract][Full Text] [Related]
9. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins.
Gupta P; Oegema TR; Brazil JJ; Dudek AZ; Slungaard A; Verfaillie CM
Blood; 2000 Jan; 95(1):147-55. PubMed ID: 10607697
[TBL] [Abstract][Full Text] [Related]
10. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma.
Verfaillie C; Blakolmer K; McGlave P
J Exp Med; 1990 Aug; 172(2):509-2. PubMed ID: 2373991
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of primitive human multipotent hematopoietic progenitors into single lineage clonogenic progenitors is accompanied by alterations in their interaction with fibronectin.
Verfaillie CM; McCarthy JB; McGlave PB
J Exp Med; 1991 Sep; 174(3):693-703. PubMed ID: 1875168
[TBL] [Abstract][Full Text] [Related]
12. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells.
Gupta P; McCarthy JB; Verfaillie CM
Blood; 1996 Apr; 87(8):3229-36. PubMed ID: 8605338
[TBL] [Abstract][Full Text] [Related]
13. Stromal factors support the expansion of the whole hemopoietic spectrum from bone marrow CD34+DR- cells and of some hemopoietic subsets from CD34+ and CD34+DR+ cells.
Herman P; Ferrant A; De Bruyère M; Straetmans N
Leukemia; 1998 May; 12(5):735-45. PubMed ID: 9593272
[TBL] [Abstract][Full Text] [Related]
14. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
[TBL] [Abstract][Full Text] [Related]
15. Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.
Cervantes F; Pierson BA; McGlave PB; Verfaillie CM; Miller JS
Blood; 1996 Mar; 87(6):2476-85. PubMed ID: 8630414
[TBL] [Abstract][Full Text] [Related]
16. A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC.
Verfaillie CM; Miller JS
Blood; 1995 Sep; 86(6):2137-45. PubMed ID: 7662962
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
18. Direct contact with stroma inhibits proliferation of human long-term culture initiating cells.
Verfaillie CM; Catanzaro P
Leukemia; 1996 Mar; 10(3):498-504. PubMed ID: 8642869
[TBL] [Abstract][Full Text] [Related]
19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow stroma damage induced by chemotherapy for acute lymphoblastic leukemia in children.
Corazza F; Hermans C; Ferster A; Fondu P; Demulder A; Sariban E
Pediatr Res; 2004 Jan; 55(1):152-8. PubMed ID: 14561785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
